Medical diagnoses can be subject to ambiguity, flux, subjectivity, and inherent uncertainty. This is particularly true in primary care, where many reported symptoms do not conform to a clear diagnosis. Thresholds around normality are often unclear.
Symptoms are commonly experienced and described as an ’iceberg’. Over a third of otherwise well people without a chronic condition have felt tired or run down, or had a headache in the previous 2 weeks, and over a quarter have had back or joint pain. Distinguishing conditions that would benefit from diagnosis and earlier intervention from those that are temporary, self-limiting, and prone to harmful medicalisation, remains challenging.
While overdiagnosis is a diagnosis of a condition that, if unrecognised, would not cause symptoms or harm, contested diagnoses are symptoms given a diagnosis, but where the diagnosis, as an explanation for them, is controversial. Opponents consider contested diagnoses ‘wrong’ not because of an error in history taking, clinical examination, or interpretation of a test result (which would risk misdiagnosis), but because the diagnosis itself, for example, chronic Lyme disease or multiple chemical sensitivity, is invalid.
Contested diagnosis is bordered by ‘pseudoscience’, for example, adrenal fatigue, leaky gut syndrome, and chronic candidiasis, which attempt to explain symptoms with ‘science’ that is demonstrably incorrect.
Many contested diagnoses relate to symptoms that are not clear-cut, meaning that some people are given a diagnosis that does not confer benefit. Others are primarily unexplained ‘yet’. For example, Gulf War syndrome was treated as a contested illness but is now recognised as caused by exposure to sarin gas. Other recognised conditions are prone to a variety of influences such that diagnosis risks causing harm, through a variable mixture of misdiagnosis, overdiagnosis, pseudoscience, or overtreatment.
A framework for considering some conditions as ‘delicate diagnoses’ may help to recognise and reduce the harms of medicine in these circumstances.
DELICATE DIAGNOSIS
A variety of models have been used to describe and explain how diagnoses are reached by doctors. Heuristics — rules-of-thumb — discounts less important information to pragmatically reach likely probabilities, while responding to environmental circumstances. Bayes’ rule means that small pieces of information can have a profound impact, with prior probabilities of disease rapidly shaping possibilities.
GPs work mainly from ‘mindlines’, ‘collectively reinforced, internalised, tacit guidelines … informed by brief reading, but mainly by their interactions with each other and with opinion leaders, patients, and pharmaceutical representatives’. Similar heuristic styles may be true for patients. This gives rise to the potential for bias, and the associated harms of poor-value care, overdiagnosis, and overtreatment.
THE PART DOCTORS AND GOVERNMENT PLAY
Finding good-quality information is often difficult. For example, searching for ‘Do I have ADHD?’ on Google brings up, in the first few hits, a trivia quiz site with an unvalidated questionnaire, a questionnaire hosted by a site sponsored by a manufacturer of drugs for ADHD, and only then, NHS information. The top hits for information about ‘cow’s milk protein allergy’ includes baby milk manufacturers and patient organisations sponsored by them. Campaigns regarding prostate cancer have been run by men’s organisations and consultants in private practice.
Nor have GPs in the UK been able to approach certain diagnoses neutrally. They have been previously financially incentivised under their contract to seek to make diagnoses ‘early’ that they would not otherwise have considered clinically useful. Despite continuity of care being desired by patients, it is in decline. Patients seek internet advice for ease, but doctors for professional skill — yet this may not be readily available given the stress in primary care.
In 2005, the Health Select Committee (HSC) review of the pharmaceutical industry argued that ‘The Department of Health has not only to promote the interests of the pharmaceutical industry but also the health of the public and the effectiveness of the NHS … The Secretary of State for Health cannot serve two masters’.
However, in 2013, the government launched Academic Health Science Networks (AHSN), seeking to increase the speed of the adoption of innovations within the NHS and ‘an entirely new relationship with industry based on partnership, not just transactions’. These delivered a programme — screening for atrial fibrillation — that the UK’s own independent committee on screening has recommended against.
In this context, full of competing interests, challenges in finding definitive evidence, and with gaps in NHS care, some diagnoses, and the circumstances in which they are likely to occur, may be considered ‘delicate’, meriting special care to navigate them. They feature many overlapping, fuzzy margins, unsettled science, and cultural differences, together with subjectivity of symptoms and risks of transactional elements (for example, payment to access a sought-after condition and associated sequelae).
These features — not intended to be exhaustive or definitive — may be especially important when considering diagnosis without the context of experienced heuristics or multiple means of sense checking via mindlines — or when these are systematically biased or based on poor information. The combination of sensitivity of area, expectations, and the difficulty of achieving certainty make them particularly prone to influence, including seeking diagnosis, and the threshold at which it is made.
A SHARED UNDERSTANDING BETWEEN DIAGNOSTICIANS, CITIZENS, AND PATIENTS
It may not be possible, or desirable, to make ‘delicate’ diagnoses more robust. Instead, a tolerance of uncertainty, and willingness to adopt a questioning, tentative, or provisional diagnosis may be appropriate. This has to be set against the potential for harm where there may be value in diagnosis and consequent treatment. However, urgent intervention in these cases is rarely needed, and rapid diagnosis has to be set against the harms of diagnostic overshadowing, low-value, and harmful medicine, and the burden of ‘patienthood’.
When the prevailing environment reflects a bias, work may be required to achieve and maintain a more neutral equipoise (Box 1). Computer coding systems may reflect a potential or uncertain diagnosis, and may require expanding to reflect uncertainty. Nor should the value of diagnosis be underplayed: the ability to name a disorder gives the ability to develop robust definitions, fairly test, and develop effective interventions.
| Type | Why | Features | Strategies |
|---|---|---|---|
| Difficult |
|
|
|
| Disputed |
|
|
|
| Desired |
|
|
|
Challenges of a ‘delicate diagnosis’
The challenge for clinicians and patients is to find benefits while avoiding harms. This may not be easy for either party, especially given the attractiveness of certainty and privileges associated with a particular diagnosis. Minimising harm and maximising benefit requires partnership between doctor and patient, especially in an environment replete with vested interests.
CONCLUSION
As medicine shifts in the era of COVID-19, new challenges are likely to impact on how and why doctors and patients seek diagnosis, and the culture in which they do it. Continuity and relationship-based care are valued but are becoming less common. A panoply of environmental pressures, some visible and some not, are prevalent. New and emerging information can be difficult to critically appraise and use, often because of biases and misinformation.
A framework to consider some diagnoses as ‘delicate’ allows for systematic identification and analysis of the influences surrounding them. This may help organise appropriate mitigations against bias, help patients and doctors avoid harm, and inform research and policy.
KEY POINTS
Some diagnoses are particularly prone to ambiguity, overdiagnosis, overtreatment, and associated harm;
systematic factors include bias, conflicts of interest, and variability in information quality for patients and clinicians;
considering certain diagnoses as ‘delicate’ allows identification and potential mitigation of these features; and
tolerance of uncertainty and willingness to adopt tentative or provisional diagnosis may be an appropriate means of balancing risks.
Footnotes
This article (with reference list and extra explanatory boxes) was first posted on BJGP Life on 7 October 2022; https://bjgplife.com/delicate
- © British Journal of General Practice 2022
In this issue
Jump to section
More in this TOC Section
Related Articles
Cited By...
